Among 28 analysts covering Autoliv Inc (NYSE:ALV), 9 have Buy rating, 8 Sell and 11 Hold. Therefore 32% are positive. Autoliv Inc has $160.0 highest and $23 lowest target. $118’s average target is -22.48% below currents $152.21 stock price. Autoliv Inc had 99 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was initiated by Wells Fargo on Monday, September 21 with “Market Perform”. The firm earned “Hold” rating on Monday, July 3 by RBC Capital Markets. RBC Capital Markets maintained Autoliv, Inc. (NYSE:ALV) rating on Sunday, August 27. RBC Capital Markets has “Hold” rating and $100.0 target. Guggenheim maintained the shares of ALV in report on Monday, January 8 with “Hold” rating. The firm has “Buy” rating given on Thursday, October 26 by Mizuho. The firm earned “Hold” rating on Tuesday, July 11 by Piper Jaffray. Citigroup upgraded it to “Hold” rating and $129.0 target in Friday, September 15 report. The stock of Autoliv, Inc. (NYSE:ALV) earned “Neutral” rating by Robert W. Baird on Friday, October 28. The stock has “Neutral” rating by Goldman Sachs on Wednesday, November 23. RBC Capital Markets maintained the stock with “Hold” rating in Monday, September 18 report. See Autoliv, Inc. (NYSE:ALV) latest ratings:
31/01/2018 Broker: Barclays Capital Old Rating: Underweight New Rating: Underweight Old Target: $94 New Target: $106 Maintain
31/01/2018 Broker: Robert W. Baird Rating: Buy Upgrade
30/01/2018 Broker: Piper Jaffray Rating: Hold New Target: $138.0 Maintain
30/01/2018 Broker: Mizuho Rating: Buy New Target: $160.0 Maintain
25/01/2018 Broker: Jefferies Rating: Buy New Target: $155.0 Maintain
18/01/2018 Broker: Cowen & Co Rating: Hold New Target: $139.0 Maintain
08/01/2018 Broker: Guggenheim Rating: Hold New Target: $135.0 Maintain
08/01/2018 Broker: Barclays Capital Rating: Sell New Target: $97.0
05/01/2018 Broker: Longbow Rating: Buy New Target: $155 Initiates Coverage On
19/12/2017 Broker: RBC Capital Markets Rating: Hold New Target: $126.0 Maintain
Meridian Bioscience Inc. (NASDAQ:VIVO) is expected to pay $0.13 on Feb 15, 2018. $0.50 is the ADY. (NASDAQ:VIVO) shareholders before Feb 2, 2018 will receive the $0.13 dividend. Meridian Bioscience Inc.’s current price of $15.65 translates into 0.80% yield. Meridian Bioscience Inc.’s dividend has Feb 5, 2018 as record date. Jan 24, 2018 is the announcement. The stock decreased 1.88% or $0.3 during the last trading session, reaching $15.65. About 218,448 shares traded. Meridian Bioscience, Inc. (NASDAQ:VIVO) has declined 26.84% since February 1, 2017 and is downtrending. It has underperformed by 43.54% the S&P500.
The stock increased 1.83% or $2.73 during the last trading session, reaching $152.21. About 1.22M shares traded or 162.08% up from the average. Autoliv, Inc. (NYSE:ALV) has declined 12.54% since February 1, 2017 and is downtrending. It has underperformed by 29.24% the S&P500.
Investors sentiment increased to 1.42 in Q3 2017. Its up 0.19, from 1.23 in 2017Q2. It is positive, as 17 investors sold Autoliv, Inc. shares while 59 reduced holdings. 40 funds opened positions while 68 raised stakes. 28.77 million shares or 2.59% more from 28.04 million shares in 2017Q2 were reported. Nuance Lc reported 30,845 shares stake. Colony Grp Limited Liability Company holds 1,968 shares. Renaissance Technologies Ltd Company reported 108,340 shares. Glenmede Na holds 0% or 271 shares in its portfolio. Quantitative Investment Mgmt Lc stated it has 58,100 shares or 0.08% of all its holdings. 9,797 are held by M&T Savings Bank Corp. Minnesota-based Murphy Pohlad Asset Management Limited Co has invested 1.57% in Autoliv, Inc. (NYSE:ALV). Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0.02% or 14,966 shares. Investor Ab holds 40,000 shares. Arrowgrass Capital (Us) L P invested in 0.1% or 107,500 shares. Acadian Asset Mgmt Lc holds 1,420 shares. 31,494 were reported by Hsbc Holding Public Ltd Com. D E Shaw Incorporated holds 0.02% or 116,273 shares in its portfolio. 2,580 were reported by Timber Hill Lc. Schroder Mgmt Group holds 0.03% or 133,400 shares in its portfolio.
Autoliv, Inc., through its subsidiaries, develops, makes, and supplies automotive safety systems to the automotive industry worldwide. The company has market cap of $13.24 billion. It operates through two divisions, Passive Safety and Electronics. It has a 31.25 P/E ratio. The firm offers a range of products, including modules and components for passenger and driver-side airbags, side-impact airbag protection systems, seatbelts, steering wheels, inflator technologies, whiplash protection systems, child seats, and components; and camera vision systems, night driving assists, automotive radars, brake controls, positioning systems, electronic control units, and other active safety systems, as well as passive safety electronic products, such as restraint electronics and crash sensors.
Investors sentiment increased to 1.37 in Q3 2017. Its up 0.02, from 1.35 in 2017Q2. It increased, as 12 investors sold Meridian Bioscience, Inc. shares while 42 reduced holdings. 24 funds opened positions while 50 raised stakes. 36.26 million shares or 2.14% more from 35.50 million shares in 2017Q2 were reported. Connors Investor Inc owns 201,852 shares. 47,902 are owned by Aperio Grp Ltd Liability Corp. 17,150 were accumulated by Teachers Retirement System Of The State Of Kentucky. 17,100 were accumulated by Louisiana State Employees Retirement Sys. The California-based Wells Fargo Mn has invested 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO). Blackrock holds 0% or 5.18 million shares. Victory Cap invested in 30,753 shares or 0% of the stock. Cornercap Investment Counsel holds 0.15% or 76,301 shares in its portfolio. Envestnet Asset Mngmt reported 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO). Voya Inv Lc owns 22,186 shares. Thrivent Finance For Lutherans invested in 25,720 shares or 0% of the stock. Spark Invest Ltd Liability has invested 0.13% in Meridian Bioscience, Inc. (NASDAQ:VIVO). Numeric Investors Limited Liability Corporation accumulated 115,763 shares. Ameriprise Fincl Inc owns 263,674 shares or 0% of their US portfolio. 51,572 are held by Royal State Bank Of Canada.
Meridian Bioscience, Inc., a life science company, develops, makes, distributes, and sells diagnostic test kits primarily for various gastrointestinal and viral diseases, respiratory and parasitic infectious diseases, and elevated blood lead levels worldwide. The company has market cap of $662.11 million. The firm operates through Diagnostics and Life Science divisions. It has a 30.69 P/E ratio. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the illumigene brand; rapid immunoassays, a single-use immunoassays under the TRU, ImmunoCard, and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the PREMIER brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare brand.
The post Meridian Bioscience Inc. (VIVO) to pay $0.13 on Feb 15, 2018; 9 Analysts Covering Autoliv, Inc. (ALV) appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/02/01/meridian-bioscience-inc-vivo-to-pay-0-13-on-feb-15-2018-9-analysts-covering-autoliv-inc-alv/
No comments:
Post a Comment